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Alcoholism is estimated to cost the 
United States a quarter of a trillion dollars 
annually, including the deaths of 88,000 
individuals. Recovering alcoholics often 
experience a multitude of withdrawal 
symptoms including long-term mood 
disturbances. Clinical studies have reported 
a strong relationship between anxiety and 
alcohol relapse, which hinders long-term 
recovery (Hershon, 1977; Cloninger, 1987; 
De Soto et al., 1989; Annis et al., 1998). 
Corticotropin-releasing factor (CRF) is a 
42-amino acid neuropeptide that regulates 
the mammalian endocrine, autonomic, 
and behavioral stress responses. Due to 
the relationship between anxiety and 
alcohol relapse, the CRF system is also an 
important mediator in enhanced alcohol 
self-administration and anxiety-related 
behaviors during acute and prolonged 
alcohol withdrawal. Research has shown 
that CRF2 receptor activation alleviates 
anxiety-related behaviors during acute 
withdrawal. Due to the long-term mood 
alterations caused by alcohol withdrawal, 
this study explored the effects of CRF2 
receptor activation on anxiety-related 
behaviors during prolonged alcohol 
withdrawal. We hypothesized that the 
activation of CRF2 receptors would 
decrease anxiety-related behaviors following 
protracted periods of alcohol withdrawal.
Male and female Wistar rats (n=16) were 
exclusively fed a liquid diet composed 
of 10% alcohol or sugar as an isocaloric 
control -for 25 days with unlimited access. 
Twenty-four hours after the removal of the 
ethanol liquid diet, rats were examined for 
signs of physical withdrawal. Afterward, 
rats were left undisturbed except for 
routine husbandry for 5 weeks prior to 
testing on the elevated plus maze, an 
animal model of anxiety. Ten minutes 
prior to testing, all rodents where given 
either 10 µg of the CRF2 receptor agonist 
Urocortin 3 (Ucn3) or vehicle only 
(control). Rodents were placed on the 
elevated plus maze for 5 minutes. Every 
entry and time spent onto each arm of 
the elevated plus maze were recorded for 
5 minutes as measures of general motor 
activity and anxiety-like behavior.
The results did support our hypothesis. 
No differences were found in body weight 
and fluid intake between all groups during 
liquid diet administration. A two-tail t-test 
confirmed that ethanol liquid diet fed rats 
experienced significantly more withdrawal 
signs compared to controls demonstrating 
that they were alcohol dependent. A 
two-way ANOVA was used to analyze 
behavior in the elevated plus maze with 
ethanol liquid diet condition and Ucn 
3 dose and between-subjects factors. A 
significant interaction between the ethanol 
liquid diet and Ucn 3 was found. Alcohol 
dependent rats that were given Ucn3 prior 
to testing spent more time on the open 
arms of the maze compared to those that 
only received vehicle. This indicates CRF2 
activation alleviates anxiety-like behaviors 
in rats experiencing prolonged alcohol 
withdrawal. No differences were found in 
the number of closed arm entries between 
groups, suggesting that differences are likely 
not due to general motor impairment.  
Limitations of this study involve a low 
number of subjects. Future research will 
benefit from larger sample sizes to better 
indicate external validity. Other animal 
models of anxiety should also be used to 
confirm that CRF2 activation can alleviate 
anxiety-like behaviors in a multitude 
of scenarios. If our initial results are 
supported, this could be an incentive for 
pharmaceutical companies to invest in the 
development of therapeutic medications 
for recovering alcoholics by targeting CRF2 
receptors to prevent anxiety related relapse. 
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